{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:19:39Z","timestamp":1784819979973,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaad.2025.01.103","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:52:40Z","timestamp":1741611160000},"page":"267-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated pemphigus patients: A retrospective analysis of 66 cases"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8383-4451","authenticated-orcid":false,"given":"Gaurav N.","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babar K.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2025.01.103_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clindermatol.2011.01.016","article-title":"Drug-induced pemphigus","volume":"29","author":"Brenner","year":"2011","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.103_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaad.2024.09.067","article-title":"Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: a retrospective study","volume":"92","author":"Ujiie","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.01.103_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107299","article-title":"Drug-induced pemphigus: a systematic review of 170 patients","volume":"92","author":"Ghaedi","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.103_bib4","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/1346-8138.14076","article-title":"Pemphigus vulgaris developing after 6-month treatment with a dipeptidyl peptidase-4 inhibitor: a case report","volume":"45","author":"Okauchi","year":"2018","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.103_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14982","article-title":"Development of pemphigus vulgaris during treatment with dipeptidyl peptidase-4 inhibitors: a case report","volume":"34","author":"Oya","year":"2021","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225004281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225004281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:47:49Z","timestamp":1766112469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225004281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0190962225004281"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.103","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated pemphigus patients: A retrospective analysis of 66 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}